148 related articles for article (PubMed ID: 8983342)
1. Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugates.
Barrett JA; Damphousse DJ; Heminway SJ; Liu S; Edwards DS; Looby RJ; Carroll TR
Bioconjug Chem; 1996; 7(2):203-8. PubMed ID: 8983342
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Barrett JA; Crocker AC; Damphousse DJ; Heminway SJ; Liu S; Edwards DS; Lazewatsky JL; Kagan M; Mazaika TJ; Carroll TR
Bioconjug Chem; 1997; 8(2):155-60. PubMed ID: 9095355
[TBL] [Abstract][Full Text] [Related]
3. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
Lister-James J; Knight LC; Maurer AH; Bush LR; Moyer BR; Dean RT
J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
[TBL] [Abstract][Full Text] [Related]
4. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
Mousa SA; Bozarth JM; Edwards S; Carroll T; Barrett J
Coron Artery Dis; 1998; 9(2-3):131-41. PubMed ID: 9647415
[TBL] [Abstract][Full Text] [Related]
5. Labeling cyclic glycoprotein IIb/IIIa receptor antagonists with 99mTc by the preformed chelate approach: effects of chelators on properties of [99mTc]chelator-peptide conjugates.
Liu S; Edwards DS; Looby RJ; Poirier MJ; Rajopadhye M; Bourque JP; Carroll TR
Bioconjug Chem; 1996; 7(2):196-202. PubMed ID: 8983341
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.
Lister-James J; Vallabhajosula S; Moyer BR; Pearson DA; McBride BJ; De Rosch MA; Bush LR; Machac J; Dean RT
J Nucl Med; 1997 Jan; 38(1):105-11. PubMed ID: 8998163
[TBL] [Abstract][Full Text] [Related]
7. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model.
Knight LC; Maurer AH; Romano JE
J Nucl Med; 1996 Mar; 37(3):476-82. PubMed ID: 8772651
[TBL] [Abstract][Full Text] [Related]
8. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom.
Knight LC; Baidoo KE; Romano JE; Gabriel JL; Maurer AH
J Nucl Med; 2000 Jun; 41(6):1056-64. PubMed ID: 10855635
[TBL] [Abstract][Full Text] [Related]
9. [Imaging of thromboembolism by scintigraphy with the 99m-technetium-labelled synthetic peptide P280].
Lastoria S; Vergara E; Varrella P; Muto P; Acampa W; Caracò C; Salvatore M
Radiol Med; 1995 Dec; 90(6):812-9. PubMed ID: 8685469
[TBL] [Abstract][Full Text] [Related]
10. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
[TBL] [Abstract][Full Text] [Related]
11. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
12. In vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligands.
Knight LC; Romano JE; Maurer AH
Thromb Haemost; 1998 Nov; 80(5):845-51. PubMed ID: 9843182
[TBL] [Abstract][Full Text] [Related]
13. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets.
Knight LC; Radcliffe R; Maurer AH; Rodwell JD; Alvarez VL
J Nucl Med; 1994 Feb; 35(2):282-8. PubMed ID: 8295000
[TBL] [Abstract][Full Text] [Related]
14. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model.
Kotzé HF; Badenhorst PN; Lamprecht S; Meiring M; Van Wyk V; Nuyts K; Stassen JM; Vermylen J; Deckmyn H
Thromb Haemost; 1995 Aug; 74(2):751-7. PubMed ID: 8585017
[TBL] [Abstract][Full Text] [Related]
15. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.
Klem JA; Schaffer JV; Crane PD; Barrett JA; Henry GA; Canestri L; Ezekowitz MD
J Nucl Cardiol; 2000; 7(4):359-64. PubMed ID: 10958278
[TBL] [Abstract][Full Text] [Related]
16. Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thrombosis.
Knight LC; Primeau JL; Siegel BA; Welch MJ
J Nucl Med; 1978 Aug; 19(8):891-4. PubMed ID: 682021
[TBL] [Abstract][Full Text] [Related]
17. Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280.
Muto P; Lastoria S; Varrella P; Vergara E; Salvatore M; Morgano G; Lister-James J; Bernardy JD; Dean RT; Wencker D
J Nucl Med; 1995 Aug; 36(8):1384-91. PubMed ID: 7629582
[TBL] [Abstract][Full Text] [Related]
18. Imaging of deep venous thrombosis using radioactive-labeled tirofiban.
Serafimovska MD; Janevik-Ivanovska E; Ugresic M; Djorgoski I
Bratisl Lek Listy; 2015; 116(10):621-6. PubMed ID: 26531874
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.
Fang W; He J; Kim YS; Zhou Y; Liu S
Bioconjug Chem; 2011 Aug; 22(8):1715-22. PubMed ID: 21780818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
